Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Oct 3;14(10):e29857.
doi: 10.7759/cureus.29857. eCollection 2022 Oct.

Bupropion-Induced Dystonia: A Case Report

Tafseer Zahra  1 , Diana Voloshyna  2 , Anan Bseiso  3   4 , Tanveer Ahamad Shaik  5 , Hayder G Ferman  6 , Meenakshi Sathish  7 , Saman Al Barznji  8 , Faraz Saleem  9 , Muhammad Abu Zar Ghaffari  9
Affiliations
Case Reports

Bupropion-Induced Dystonia: A Case Report

Tafseer Zahra et al. Cureus. .

Abstract

Bupropion is one of the most commonly prescribed antidepressant medications by physicians all over the world. Because of its favorable sexual profile, it is used as an alternative to serotonin reuptake inhibitors (SSRIs). Its significance in smoking cessation is also well recognized. However, it is associated with a few side effects, such as dizziness, anxiety, tremors, nausea, and insomnia. We present the case of a 54-year-old chronic smoker who developed acute facial dystonia involving the temporomandibular joint (TMJ) after being prescribed 300 mg of bupropion. The Naranjo scale was used to assess the probability of bupropion-induced dystonia. Following the diagnosis, the drug was stopped, and the dystonia completely resolved within one week. At her follow-ups, the patient was found to have no recurrence of dystonia.

Keywords: antidepressant drug; bupropion; drug induced dystonia; drug induced dystonia (did); dystonia.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. Dwoskin LP, Rauhut AS, King-Pospisil KA, Bardo MT. CNS Drug Rev. 2006;12:178–207. - PMC - PubMed
    1. A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S. Prim Care Companion J Clin Psychiatry. 2004;6:159–166. - PMC - PubMed
    1. Does bupropion impact more than mood? A case report and review of the literature. Yasin W, Ahmed SI, Gouthro RV. Cureus. 2019;11:0. - PMC - PubMed
    1. Extrapyramidal reactions to metoclopramide and prochlorperazine. Bateman DN, Darling WM, Boys R, Rawlins MD. https://pubmed.ncbi.nlm.nih.gov/2594960/ Q J Med. 1989;71:307–311. - PubMed
    1. Acute dystonia induced by lamivudine. Song X, Hu Z, Zhang H. Clin Neuropharmacol. 2005;28:193–194. - PubMed

Publication types

LinkOut - more resources